Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy

Survival in non-small cell lung cancer (NSCLC) remains poor; in the UK less than 10% of patients survive at five years. This is despite recent advances in radiotherapy technology that have enabled a larger proportion of locally advanced patients to be treated with curative intent, while maintaining the dose received by normal tissues within acceptable safety limits [1,2].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research